An MSL, or Medical Science Liaison, is a field-based scientific expert employed by a pharmaceutical company to serve as a bridge between the company and the medical community. Unlike sales representatives, MSLs don’t promote or sell products. Their job is to engage physicians and researchers in non-promotional, peer-level scientific discussions about diseases, therapies, and clinical data. The role was first created in 1967 by the Upjohn Corporation and has since become a staple of nearly every major pharma and biotech company’s medical affairs team.
What MSLs Actually Do Day to Day
MSLs spend most of their time traveling to academic medical centers, hospitals, and research sites to meet face-to-face with physicians, researchers, and other healthcare professionals. These aren’t sales calls. The conversations are scientific: discussing newly published clinical trial results, explaining the mechanism behind a therapy, or answering detailed medical questions that a sales rep wouldn’t be qualified to address.
A large part of the role revolves around building and maintaining relationships with Key Opinion Leaders, commonly called KOLs. These are influential physicians and researchers whose expertise shapes how a disease area is understood and treated. MSLs are expected to know the latest published research well enough to discuss it with these specialists on equal footing. Companies track the depth and frequency of these interactions as a core performance measure.
Beyond KOL engagement, MSLs take on a range of responsibilities:
- Clinical trial support. They help activate trial sites, clarify protocols for investigators, and troubleshoot patient recruitment challenges, especially in rare disease studies where protocols can be complex.
- Advisory boards. They organize and attend meetings where physicians provide real-time feedback on product development, trial design, or medical strategy.
- Internal education. They train sales teams on the science behind a product so reps can speak accurately about its benefits, even though the MSL themselves stays out of the selling process.
- Field intelligence. They feed insights back to R&D and medical affairs teams, acting as an early-warning system for shifts in how physicians perceive a product or where unmet clinical needs are emerging.
How MSLs Differ From Sales Reps
The distinction between an MSL and a pharmaceutical sales representative is one of the most important things to understand about the role. Sales reps promote products. MSLs cannot. Every interaction an MSL has with a healthcare professional must be non-promotional, balanced, and grounded in scientific evidence. This isn’t just company policy; it’s a regulatory requirement enforced by the FDA, EMA, and industry codes of conduct.
To protect that boundary, MSL teams almost always report into a company’s Medical Affairs division rather than the commercial or sales organization. This structural separation reinforces the independence of the role. While sales reps are measured on prescriptions and revenue, MSLs are evaluated on the quality and depth of their scientific relationships, the number of KOLs they engage, and the feedback they channel back to the company.
MSLs work with physicians at a clinical and academic level. A sales rep handles the day-to-day business relationship. Both roles are customer-facing, but the nature of the conversation is fundamentally different.
Off-Label Information and Compliance
One area where the MSL role gets legally sensitive is off-label information. Pharmaceutical companies cannot promote a drug for uses the FDA hasn’t approved. However, physicians can and do prescribe drugs off-label, and they sometimes have scientific questions about those uses.
MSLs are allowed to respond to these questions, but only reactively. If a physician asks an unsolicited question about an off-label use, the MSL can provide a focused, balanced, evidence-based response. What they cannot do is proactively bring up off-label uses or steer a conversation toward them. Scientific exchange should never contain false or misleading information, or selectively omit data in a way that could mislead the physician. MSLs are expected to have a strong understanding of the relevant industry codes in whatever country they operate, including local policies governing interactions with healthcare providers.
Education and Qualifications
In the United States, more than 90% of MSLs hold a doctoral-level degree: a PhD, PharmD, MD, or DNP. The expectation is that you can sit across from a specialist physician and hold a scientific conversation as a peer, which generally requires that level of training. Outside the US, requirements vary. In some countries, 40 to 60% of MSLs do not hold a terminal doctoral degree, and a master’s in a relevant science field may be sufficient.
There’s also a professional certification available, the Board-Certified Medical Science Liaison credential (BC-MSL), which some candidates pursue to strengthen their profile when breaking into the field. Therapeutic expertise matters too. An MSL covering oncology needs deep knowledge of cancer biology and treatment landscapes, not just a general science background.
Salary and Compensation
MSL roles pay well relative to other life sciences positions. In the US, entry-level MSLs (sometimes titled Associate MSL or Junior MSL) typically start with a base salary between $115,000 and $135,000, which already exceeds many mid-level clinical research coordinator and clinical research associate roles. Annual bonuses generally range from 10 to 25% of base salary, with higher percentages common in commercial-heavy therapeutic areas. Senior MSLs and those in leadership positions earn significantly more.
Travel and Territory
Travel is one of the defining features of the MSL lifestyle. MSLs are field-based, meaning they work from home but spend a significant portion of their time on the road visiting healthcare professionals across a designated geographic territory. Territory sizes vary enormously depending on the therapeutic area and the density of relevant medical centers. Some MSLs cover a few counties in a major metro area. Others are responsible for eight or more states.
Data from MSL territory surveys collected between 2021 and 2023 show that field days per month can range from around 5 to 17, depending on territory size and the concentration of KOLs in the region. Smaller, denser territories mean more face-to-face meetings and shorter drives. Larger territories often involve flights and overnight stays, which is a real consideration for anyone with a family or other commitments that make frequent travel difficult.
Where MSLs Fit in a Drug’s Lifecycle
MSLs aren’t just relevant once a drug hits the market. They’re involved across the entire product lifecycle. Before a drug launches, MSLs help identify potential clinical trial investigators, educate site staff on protocols, and build relationships with the physicians who will eventually treat patients with the therapy. During the launch phase, they provide non-promotional scientific education to specialists who need to understand the clinical data before making prescribing decisions. Post-launch, they continue to share new data as it’s published, gather physician feedback, and support investigator-initiated research where physicians design their own studies using the company’s product.
This long arc of involvement is part of what makes the role appealing to scientists who want to stay connected to clinical medicine without practicing it directly. MSLs sit at the intersection of research, medicine, and industry, translating science in both directions: from the company to the medical community, and from the field back to the company’s development teams.